Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery

Ihse, 1979, Working party report to the world congresses of gastroenterology, Sydney 1990, J Gastroenterol Hepatol, 6, 423, 10.1111/j.1440-1746.1991.tb00884.x Niederau, 1992, Diagnosis of pancreatic carcinoma, Pancreas, 1, 66, 10.1097/00006676-199201000-00011 1993, Tumour staging in gastrointestinal tumours, Endoscopy, 25, 1 Neville, 1976, Biochemical monitoring of cancer, Ann Clin Biochem, 13, 283, 10.1177/000456327601300101 Roberts, 1989, Clinical value of tumour markers, Ann Chir Gyn, 78, 1 Woolfson, 1991, Tumor markers in cancer of the colon and rectum, Dis Colon Rectum, 34, 506, 10.1007/BF02049939 Eskelinen, 1994, Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer, Anticancer Res, 14, 1427 Hollinshead, 1977, Interrelationship of prealbumin and alpha-1 acid glycoprotein in cancer patient sera, Cancer, 40, 2993, 10.1002/1097-0142(197712)40:6<2993::AID-CNCR2820400635>3.0.CO;2-I Ward, 1977, Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes, Br J Cancer, 35, 170, 10.1038/bjc.1977.24 Milano, 1978, Serum prealbumin, retinol-binding protein, transferrin, and albumin levels in patients with large bowel cancer, J Natl Cancer Inst, 61, 687 Bastable, 1979, Acute phase reactant proteins in the clinical management of carcinoma of the bladder, Br J Urol, 51, 283, 10.1111/j.1464-410X.1979.tb04710.x Cooper, 1979, Acute phase reactant proteins in cancer, Adv Cancer Res, 30, 1, 10.1016/S0065-230X(08)60893-3 Velde, 1979, Acute phase reactants and complement components as indicators of recurrence in human cervical cancer, Eur J Cancer, 15, 893, 10.1016/0014-2964(79)90231-7 Trautner, 1980, An evaluation of serum protein profiles in the long-term surveillance of prostatic cancer, Scand J Urol Nephrol, 14, 143, 10.3109/00365598009179552 Drahovsky, 1981, Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion, Oncology, 38, 286, 10.1159/000225572 O'Quigley, 1981, Prognostic significance of serum proteins in invasive bladder cancer, Eur J Cancer, 17, 251, 10.1016/0014-2964(81)90044-X Richards, 1982, Serum protein profiles in carcinoma of the kidney, Eur Urol, 8, 32, 10.1159/000473474 de Mello, 1983, Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer, Br J Cancer, 48, 341, 10.1038/bjc.1983.198 Raynes, 1983, Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease, J Clin Pathol, 36, 798, 10.1136/jcp.36.7.798 Walker, 1983, Acute-phase reactant proteins and carcinoembryonic antigen in cancer of the colon and rectum, Cancer, 52, 150, 10.1002/1097-0142(19830701)52:1<150::AID-CNCR2820520127>3.0.CO;2-0 Durdey, 1984, Serum carcinoembryonic antigen and acute phase reactant proteins in the pre-operative detection of fixation of colorectal tumours, Br J Surg, 71, 881, 10.1002/bjs.1800711126 Ganz, 1984, Monitoring the therapy of lung cancer with alpha-1-acid glycoprotein, Cancer Res, 44, 5415 Weinstein, 1984, Acute-phase proteins or tumor markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases, Scand J Immunol, 19, 193, 10.1111/j.1365-3083.1984.tb00919.x Büchler, 1987, C-reaktives Protein als Entzündungs- und Nekrosemarker in der Gastroenterologi, Med Klin, 82, 180 Göransson, 1991, Plasma levels of C-reactive protein in the diagnosis of acute abdominal disease, Surg Res Comm, 11, 107 vall Lundqvist, 1991, Pretreatment serum levels of C-reactive protein, alpha-1-antitrypsin, haptoglobin, alpha-1-acid glycoprotein and tissue polypeptide antigen in cervical carcinoma, Eur J Gynaec Oncol, 12, 375 Ballou, 1992, C-reactive protein and the acute phase response, Adv Intern Med, 37, 313 Lasson, 1992, Plasma CRP-levels in the diagnosis of postoperative complications, Surg Res Comm, 12, 203 Stamatiadis, 1992, Combination of serum carcino—embryonic antigen and C-reactive protein—a useful test in preoperative staging of colorectal cancer, Eur J Surg Oncol, 18, 41 Fuchs, 1992, The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant disease, Crit Rev Clin Lab Sci, 29, 307, 10.3109/10408369209114604 Blay, 1992, Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma, Cancer Res, 52, 3317 Barch-Mortensen, 1975, C1-esterase inactivators and C4 in malignant disease, Lancet, 13, 499, 10.1016/S0140-6736(75)90571-1 Astrup, 1977, Complement C1-inactivator in the serum of patients with malignant disease, Acta Radiol Ther Phys Biol, 16, 394, 10.3109/02841867709133960 Janssen, 1983, Stage-related correlations between immunoglobulins and complement components in preoperative sera from patients with gastric carcinoma, Eur J Cancer Clin Oncol, 19, 1601, 10.1016/0277-5379(83)90092-5 Janssen, 1987, Preoperative prediction of extent and prognosis of gastric carcinoma by four serum proteins and erythrocyte sedimentation rate, Eur J Surg Oncol, 13, 285 Janssen, 1990, Who gets a second primary cancer after gastric cancer surgery?, Eur J Surg Oncol, 16, 195 Janssen, 1992, The influence of the host on the course of gastric carcinoma, Br J Cancer, 66, 870, 10.1038/bjc.1992.376 Starcevic, 1991, Plasma C1 inhibitor in malignant diseases: Functional activity versus concentration, Ann Clin Biochem, 28, 595, 10.1177/000456329102800609 Roeise, 1990, Studies on components of the contact phase system in patients with advanced gastrointestinal cancer, Cancer, 65, 1355, 10.1002/1097-0142(19900315)65:6<1355::AID-CNCR2820650618>3.0.CO;2-1 Ades, 1982, Modulation of the immune response by plasma protease inhibitors, Scand J Immunol, 15, 109, 10.1111/j.1365-3083.1982.tb00628.x Donnelly, 1983, The role of protease in immunoregulation, Br J Surg, 70, 614, 10.1002/bjs.1800701015 Taylor, 1991, Effect of alpha-2-macroglobulin on cytokine-mediated human C-reactive protein production, Inflammation, 15, 61, 10.1007/BF00917910 Borth, 1994, Alpha-2-macroglobulin, Ann NY Acad Sci, 267, 10.1111/j.1749-6632.1994.tb44317.x Broom, 1992, Interleukin 2 therapy in cancer; identification of responders, Br J Cancer, 66, 1185, 10.1038/bjc.1992.433 1987 Turnbull, 1967, Cancer of the colon: the influence of the no-touch isolation technic on survival rates, Ann Surg, 166, 420, 10.1097/00000658-196709000-00010 1995, Vol. 22 Laurell, 1972, Electroimmunoassay, Scand J Clin Lab Invest, 29, 21, 10.3109/00365517209102748 Friberger, 1982, Chromogenic peptide substrates, 42, 84 1982 Osther, 1974, C1 inactivator from cancer cells, Lancet, 2, 359, 10.1016/S0140-6736(74)93117-1 Coombes, 1977, Biochemical markers in human breast cancer, Lancet, 15, 132, 10.1016/S0140-6736(77)91719-6 Hillyard, 1982, Biochemical aids to the staging of breast cancer, Clin Biochem, 15, 9, 10.1016/S0009-9120(82)90295-8 Robertson, 1991, Prospective assessment of the role of five tumour markers in breast cancer, Cancer Immunol Immunother, 33, 403, 10.1007/BF01741602 Chisholm, 1986, The role of a questionnaire and four biochemical markers to detect cancer risk in a symptomatic population, Br J Cancer, 53, 53, 10.1038/bjc.1986.8 Bataille, 1992, C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system, Blood, 80, 733, 10.1182/blood.V80.3.733.733 Safi, 1993, Is follow-up of colorectal cancer patients worthwhile?, Dis Colon Rectum, 36, 636, 10.1007/BF02238589 Vernava, 1994, Current follow-up strategies after resection of colon cancer, Dis Colon Rectum, 37, 573, 10.1007/BF02050993 Lindmark, 1994, Prognostic predictors in colorectal cancer, Dis Colon Rectum, 37, 1219, 10.1007/BF02257785 Moertel, 1986, The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer, Cancer, 58, 603, 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K